Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism
Abstract
Background Primary hyperparathyroidism is associated with an increased cardiovascular morbidity and mortality. However, mechanisms underlying this association are currently unclear. As there is clear evidence of the independent role of aldosterone on the cardiovascular system, the aim of this study was to evaluate aldosterone levels in patients with primary hyperparathyroidism.Methods A prospective study of 134 consecutive patients with primary hyperparathyroidism before and 3 months after parathyroidectomy.Results Pre-operative serum aldosterone and parathyroid hormone (PTH) levels were correlated positively in all patients (.238; P = .005). In the 62 patients (46%) that were not on antihypertensive medications, this correlation was stronger (.441; P = .0003). In the 72 patients (54%) treated with at least 1 antihypertensive medication, no correlation between preoperative aldosterone and PTH serum levels was observed. By multivariate analysis, pre-operative PTH level (.409; P = .005) was an independent predictor of aldosterone. Pre-operative PTH level >100 ng/L was an independent predictor of abnormally elevated plasma aldosterone level (odds ratio 3.5; P = .01). At 3 months after parathyroidectomy, no correlation was observed between postoperative PTH and aldosterone levels.Conclusion Aldosterone is correlated positively to preoperative PTH levels in patients with primary hyperparathyroidism. Aldosterone might be a key mediator of cardiovascular symptoms in patients with primary hyperparathyroidism.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 683 · see citing works
Renin-angiotensin system and cardiovascular risk
Schmieder, R. E., Hilgers, K. F., Schlaich, M. P., & Schmidt, B. M. W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60242-6 · Cited by 659 · see citing works
Seifarth, C., Trenkel, S., Schobel, H.-P., Hahn, E. G., & Hensen, J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01613.x · Cited by 176 · see citing works
Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism
Vestergaard, P., & Mosekilde, L. (2003) · BMJ · doi:10.1136/bmj.327.7414.530 · Cited by 168 · see citing works
Massimo, P., Magro, G. G., Cesario, F., Piovesan, A., Pia, A., Molineri, N., & Borretta, G. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00809.x · Cited by 123 · see citing works
Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension
El‐Gharbawy, A., NADIG, V., Kotchen, J. M., Grim, C. E., Sagar, K. B., Kaldunski, M. L., Hamet, P., Pausová, Z., Gaudet, D., Gossard, F., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.845 · Cited by 108 · see citing works
Gennari, C., Nami, R., & Gonnelli, S. (1995) · PubMed · Cited by 86 · see citing works
Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems
Grant, F. D., Mandel, S. J., Brown, E. M., Williams, G. H., & Seely, E. W. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400892 · Cited by 76 · see citing works
Kovacs, L., Goth, M., Szabolcs, I., Dohan, O., Ferencz, A., & Szilagyi, G. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380543 · Cited by 66 · see citing works
Long‐term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension
Sancho, J., Rouco, J., Riera‐Vidal, R., & Sitges‐Serra, A. (1992) · World Journal of Surgery · doi:10.1007/bf02067371 · Cited by 63 · see citing works
Schlaich, M. P., Schobel, H. P., Hilgers, K. F., & Schmieder, R. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00728-1 · Cited by 59 · see citing works
Clinical update: sporadic primary hyperparathyroidism
Sitges‐Serra, A., & Bergenfelz, A. O. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61213-6 · Cited by 57 · see citing works
Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy
Salahudeen, A. K., Thomas, T. H., Sellars, L., Tapster, S., KEAVEY, P. M., Farndon, J. R., Johnston, I. D. A., & Wilkinson, R. (1989) · Clinical Science · doi:10.1042/cs0760289 · Cited by 50 · see citing works
Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery
Bernini, G., Moretti, A., Lonzi, S., Bendinelli, C., Miccoli, P., & Salvetti, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90075-6 · Cited by 40 · see citing works
Hormone, calcium and blood pressure relationships in primary hyperparathyroidism
Richards, M., Espiner, E. A., Nicholls, M. G., Ikram, H., Hamilton, E. J., & Maslowski, A. H. (1988) · Journal of Hypertension · doi:10.1097/00004872-198809000-00009 · Cited by 37 · see citing works
Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone.
Ølgaard, K., Lewin, E., Bro, S., Daugaard, H., Egfjord, M., & Pless, V. (1994) · PubMed · Cited by 34 · see citing works
Primary hyperparathyroidism and the cardiovascular system
Kiernan, T. J., O’Flynn, A. M., McDermott, J. H., & Kearney, P. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.05.033 · Cited by 28 · see citing works
Aldosterone and Telomere Length in White Blood Cells
Benetos, A., Gardner, J. P., Kimura, M., Labat, C., Nzietchueng, R., Dousset, B., Zannad, F. M., Lacolley, P. J., & Aviv, A. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.12.1593 · Cited by 28 · see citing works
Primary Hyperparathyroidism: Possible Cause of Primary Hyperaldosteronism in a 60-Year-Old Woman*
Barkan, A., Marilus, R., Winkelsberg, G., Yeshurun, D., & Blum, I. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-1-144 · Cited by 27 · see citing works
Effect of Parathyroidectomy on Cardiac Fibrosis and Apoptosis: Possible Role of Aldosterone
Rodríguez-Ayala, E., Ávila–Díaz, M., Foyo-Niembro, E., Amato, D., Juan, E. R., & Paniagua, R. (2006) · Nephron Physiology · doi:10.1159/000092244 · Cited by 24 · see citing works
The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism
Ganguly, A., Weinberger, M. H., Passmore, J. M., Caras, J. A., KHAIRI, R. M. A., Grim, C. E., Edmonson, J., & Johnston, C. C. (1982) · Metabolism · doi:10.1016/0026-0495(82)90098-1 · Cited by 17 · see citing works
Jespersen, B., Pedersen, E. B., Charles, P., Danielsen, H., & Juhl, H. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200362 · Cited by 13 · see citing works
Aldosterone and pressor responses to angiotensin II in primary hyperparathyroidism
Fallo, F., Rocco, S., Pagotto, U., Zangari, M., Luisetto, G., & Mantero, F. (1989) · Journal of Hypertension · doi:10.1097/00004872-198900076-00092 · Cited by 11 · see citing works
Jespersen, B., Brock, A., Charles, P., Danielsen, H., Sørensen, S. S., & Pedersen, E. B. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519309092543 · Cited by 4 · see citing works
Too Much Aldosterone—More Common Than We Ever Realized?
PRATT, J. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.09.004 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Tomaschitz, A., Ritz, E., Pieske, B. M., Rus-Machan, J., Kienreich, K., Verheyen, N., Gaksch, M., Grübler, M. R., Fahrleitner‐Pammer, A., Mrak, P., et al. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.016 · Cited by 167 · see citing works
Cardiovascular manifestations of primary hyperparathyroidism: a narrative review
Pepe, J., Cipriani, C., Sonato, C., Raimo, O., Biamonte, F., & Minisola, S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0485 · Cited by 165 · see citing works
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 159 · see citing works
Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress
Renke, G., Starling-Soares, B., Baesso, T., Petronio, R., Aguiar, D., & Paes, R. (2023) · Nutrients · doi:10.3390/nu15030769 · Cited by 141 · see citing works
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease
Tomaschitz, A., Ritz, E., Pieske, B. M., Fahrleitner‐Pammer, A., Kienreich, K., Horina, J. H., Drechsler, C., März, W., Ofner, M., Pieber, T. R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs092 · Cited by 129 · see citing works
Pilz, S., Kienreich, K., Drechsler, C., Ritz, E., Fahrleitner-Pammer, A., Gaksch, M., Meinitzer, A., März, W., Pieber, T. R., & Tomaschitz, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2183 · Cited by 118 · see citing works
Osto, E., Fallo, F., Pelizzo, M. R., Maddalozzo, A., Sorgato, N., Corbetti, F., Montisci, R., Famoso, G., Bellu, R., Lüscher, T. F., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.081307 · Cited by 81 · see citing works
Rossi, G. P., Ragazzo, F., Seccia, T. M., Maniero, C., Barisa, M., Calò, L. A., Frigo, A. C., Fassina, A., & Pessina, A. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195891 · Cited by 76 · see citing works
Brown, J., de Boer, I. H., Robinson-Cohen, C., Siscovick, D. S., Kestenbaum, B., Allison, M., & Vaidya, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3949 · Cited by 71 · see citing works
Epidemiology of primary hyperparathyroidism.
Clarke, B. (2013) · Journal of clinical densitometry · doi:10.1016/j.jocd.2012.11.009 · Cited by 51 · see citing works
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
Zheng, M.-H., Li, F., Xu, F., Lin, X., Wang, Y., Xu, Q.-S., Guo, B., & Yuan, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00539 · Cited by 67 · see citing works
Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy
Rosa, J., Raška, I., Wichterle, D., Petrák, O., Štrauch, B., Krátká, Z., Zelinka, T., Holaj, R., & Widimsky, J., Jr. (2010) · Hypertension Research · doi:10.1038/hr.2010.232 · Cited by 52 · see citing works
Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited
Borkowski, B., Cheema, Y., Shahbaz, A. U., Bhattacharya, S. K., & Weber, K. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr063 · Cited by 49 · see citing works
Parathyroid Hormone, A Crucial Mediator of Pathologic Cardiac Remodeling in Aldosteronism
Rutledge, M., Farah, V., Adeboye, A. A., Seawell, M. R., Bhattacharya, S. K., & Weber, K. T. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6378-0 · Cited by 41 · see citing works
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health
Brown, J. M., & Vaidya, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000062 · Cited by 39 · see citing works
Fischer, E., Hannemann, A., Rettig, R., Lieb, W., Nauck, M., Pallauf, A., Bildingmaier, M., Beuschlein, F., Wallaschofski, H., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3214 · Cited by 37 · see citing works
Frey, S., Mirallié, É., Cariou, B., & Blanchard, C. L. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.029 · Cited by 37 · see citing works
Gao, X., Yamazaki, Y., Tezuka, Y., Onodera, Y., Ogata, H., Omata, K., Morimoto, R., Nakamura, Y., Satoh, F., & Sasano, H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105434 · Cited by 32 · see citing works
Pepe, J., Diacinti, D., Fratini, E., Nofroni, I., D’Angelo, A., Pilotto, R., Savoriti, C., Colangelo, L., Raimo, O., Cilli, M., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1152 · Cited by 31 · see citing works
Fisher, A. A., Srikusalanukul, W., Davis, & Smith (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s38856 · Cited by 30 · see citing works
Coronary artery disease is more severe in patients with primary hyperparathyroidism
Koubaity, O., Mandry, D., Nguyen‐Thi, P., Bihain, F., Nominé-Criqui, C., Demarquet, L., Laurent, V., & Brunaud, L. (2019) · Surgery · doi:10.1016/j.surg.2019.05.094 · Cited by 28 · see citing works
Self-citationTomaschitz, A., Fahrleitner‐Pammer, A., Pieske, B. M., Verheyen, N., Amrein, K., Ritz, E., Kienreich, K., Horina, J. H., Schmidt, A. G., Kraigher‐Krainer, E., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-19 · Cited by 26 · see citing works
Asbach, E., Bekeran, M., König, A., Lang, K., Hanslik, G., Treitl, M., Ladurner, R., Bidlingmaier, M., Beuschlein, F., Quinkler, M., et al. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1027-6472 · Cited by 25 · see citing works
Tomaschitz, A., Verheyen, N., Meinitzer, A., Pieske, B., Belyavskiy, E., Brussee, H., Haas, J., März, W., Pieske-Kraigher, E., Verheyen, S., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000927 · Cited by 24 · see citing works
Kong, S.-K., Tsai, M.-C., Yeh, C.-L., Tsai, Y.-C., Chien, M.-N., Lee, C., & Tsai, W.-H. (2024) · Bone · doi:10.1016/j.bone.2024.117130 · Cited by 25 · see citing works
Verheyen, N., Fahrleitner-Pammer, A., Pieske, B., Meinitzer, A., Belyavskiy, E., Wetzel, J., Gaksch, M., Grübler, M. R., Catena, C., Sechi, L. A., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001004 · Cited by 24 · see citing works
Parathyroid Gland Function in Primary Aldosteronism
Bekeran, M., Reincke, M., & Asbach, E. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565224 · Cited by 22 · see citing works
Martín‐Fernández, B., Heras, N. D. L., Miana, M., Ballesteros, S., Delgado, C., Song, S. S., Hintze, T. H., Cachofeiro, V., & Lahera, V. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31820088ca · Cited by 22 · see citing works
Aldosterone and Parathyroid Hormone: A Complex and Clinically Relevant Relationship
Pilz, S., Tomaschitz, A., März, W., Cavalier, E., & Ritz, E. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9409-5 · Cited by 21 · see citing works
Mateus‐Hamdan, L., Beauchet, O., Bouvard, B., Legrand, É., Fantino, B., & Annweiler, C. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00945.x · Cited by 20 · see citing works
Robinson, A., Newman, K. P., Weber, K. T., Ramanathan, K. B., & McGee, J. E. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182231ee3 · Cited by 20 · see citing works
Factors affecting parathyroid hormone levels in different types of primary aldosteronism
Jiang, Y., Zhang, C., Ye, L., Su, T., Zhou, W., Jiang, L., Zhang, Y., & Wang, W. (2015) · Clinical Endocrinology · doi:10.1111/cen.12981 · Cited by 20 · see citing works
Loh, H. H., & Sukor, N. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0294-8 · Cited by 19 · see citing works
Tuersun, T., Luo, Q., Zhang, Z., Wang, G., Zhang, D., Wang, M., Wu, T., Zhou, K., Yue, N., & Li, N. (2020) · Hypertension Research · doi:10.1038/s41440-020-0529-7 · Cited by 18 · see citing works
Özdemir, D., Kalkan, G. Y., Bayram, N., Önal, E. D., Ersoy, R., Bozkurt, E., & Çakır, B. (2014) · Endocrine · doi:10.1007/s12020-014-0245-7 · Cited by 18 · see citing works
Disturbances in Calcium Metabolism and Cardiomyocyte Necrosis: The Role of Calcitropic Hormones
Yusuf, J., Khan, M. U., Cheema, Y., Bhattacharya, S. K., & Weber, K. T. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.02.004 · Cited by 16 · see citing works
Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio
the Chongqing Primary Aldosteronism Study(CONPASS) Group, Shu, X., Mei, M., Ma, L., Wang, Z., Yang, S., Hu, J., Song, Y., He, W., Luo, T., et al. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0069-7 · Cited by 15 · see citing works
Shaheen, M. H., Cheema, Y., Shahbaz, A. U., Bhattacharya, S. K., & Weber, K. T. (2011) · PubMed Central · Cited by 14 · see citing works
Primary hyperparathyroidism: an update
Habib, Z. A., & Camacho, P. M. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833f47e4 · Cited by 14 · see citing works
Muller, M.-E., Ogna, V. F., Maillard, M. P., Stoudmann, C., Zweiacker, C., Anex, C., Wuerzner, G., Burnier, M., & Bonny, O. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1714-4 · Cited by 14 · see citing works
Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
Zaheer, S., Brown, J. M., Connors, M., Williams, J. S., Adler, G. K., & Vaidya, A. (2017) · International Journal of Endocrinology · doi:10.1155/2017/4138783 · Cited by 12 · see citing works
Primary Hyperaldosteronism: When to Suspect It and How to Confirm Its Diagnosis
Ruiz-Sánchez, J. G., Pazos, M., Meneses, D., & Rünkle, I. (2022) · Endocrines · doi:10.3390/endocrines3010003 · Cited by 12 · see citing works
Matzen, J., Bislev, L. S., Sikjær, T., Rolighed, L., Hitz, M. F., Eiken, P., Hermann, A. P., Jensen, J. B., Abrahamsen, B., & Rejnmark, L. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00918-z · Cited by 10 · see citing works
The Relationship Between Renal Stones and Primary Aldosteronism
Chang, C.-K., Chang, C., Wu, V., Geng, J., & Lee, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.828839 · Cited by 9 · see citing works
Stanić, B. M., Ilinčić, B., Žeravica, R., Ivanovski, D. M., Čabarkapa, V., & Mijović, R. (2022) · International Journal of Endocrinology · doi:10.1155/2022/3804899 · Cited by 8 · see citing works
Stressor States and the Cation Crossroads
Weber, K. T., Bhattacharya, S. K., Newman, K. P., Soberman, J. E., Ramanathan, K. B., McGee, J. E., Malik, K. U., & Hickerson, W. L. (2010) · Journal of the American College of Nutrition · doi:10.1080/07315724.2010.10719895 · Cited by 8 · see citing works
Bislev, L. S., Sikjær, T., Rolighed, L., & Rejnmark, L. (2015) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-015-9182-0 · Cited by 8 · see citing works
Connecting the dots: renin-angiotensin-aldosterone system, vitamin D, and hypertension
Loh, H. H., Azizan, E. A., & Sukor, N. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004046 · Cited by 6 · see citing works
Trandafir, A.-I., Gheorghe, A.-M., Sima, O.-C., Ciuche, A., Petrova, E. N., Nistor, C., & Carşote, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417338 · Cited by 6 · see citing works
Mineralocorticoid Receptor Antagonism Confers Cardioprotection in Heart Failure
Seawell, M. R., Darazi, F. A., Farah, V., Ramanathan, K. B., Newman, K. P., Bhattacharya, S. K., & Weber, K. T. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0120-x · Cited by 6 · see citing works
Does angiotensin II regulate parathyroid hormone secretion or not?
Rossi, G. P., & Prisco, S. (2018) · Clinical Endocrinology · doi:10.1111/cen.13798 · Cited by 5 · see citing works
Park-Sigal, J. J., Don, B. R., Porzig, A. M., Recker, R. R., Griswold, V. J., Sebastián, A., Duh, Q., Portale, A. A., Shoback, D., & Schambelan, M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1791 · Cited by 5 · see citing works
Hyperparathyroidism in patients with overt and mild primary aldosteronism
Gravvanis, C., Papanastasiou, L., Glycofridi, S., Voulgaris, N., Tyfoxylou, E., Kounadi, T., Piaditis, G. P., & Markou, Α. (2021) · HORMONES · doi:10.1007/s42000-021-00319-w · Cited by 5 · see citing works
Dobreva, E. A., Евгеньевна, Б. Е., Константиновна, Е. А., Rebrova, O. Y., Nikankina, L. V., Malysheva, N. M., & Mokrysheva, N. G. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-6-630-638 · Cited by 5 · see citing works
Dobreva, E. A., Bibik, E. E., Eremkina, A. K., Ajnetdinova, A. R., Nikankina, L. V., Malysheva, N. M., & Mokrysheva, N. G. (2020) · Terapevticheskii Arkhiv · doi:10.26442/00403660.2020.10.000725 · Cited by 4 · see citing works
“Однако через 3 мес после ПТЭ отмечено повышение концентрации альдостерона плазмы (p=0,01) [32].”
Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension
Castellano, E., Pellegrino, M., Tardivo, V., Attanasio, R., Boriano, A., & Borretta, G. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.886 · Cited by 4 · see citing works
The relationship between primary hyperparathyroidism and frontal QRS-T angle
Apak, O., Avcı, B. Ş., Apak, O., Avcı, A., Tuğcan, M. O., Yildirim, A., Koç, M., & Saler, T. (2025) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2025.153935 · Cited by 3 · see citing works
Aldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship
Naik, V. (2019) · Journal of Endocrinology and Thyroid Research · doi:10.19080/jetr.2019.04.555637 · Cited by 3 · see citing works
Sporadic primary hyperparathyroidism: medical and surgical updates
Habib, Z. A., Kabaker, A. S., & Camacho, P. M. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.867803 · Cited by 2 · see citing works
Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations
Barale, M., Maiorino, F., Pusterla, A., Fraire, F., Sauro, L., Presti, M., Sagone, N., Ghigo, E., Arvat, E., & Massimo, P. (2024) · Endocrine · doi:10.1007/s12020-024-04063-0 · Cited by 2 · see citing works
Effects of Altered Calcium Metabolism on Cardiac Parameters in Primary Aldosteronism
Lim, J. S., Hong, N., Park, S., Park, S. I., Oh, Y. T., Yu, M. H., Lim, P. Y., & Rhee, Y. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.4.485 · Cited by 2 · see citing works
Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO
Iriarte-Durán, M. B., Paja, M., Gellida, A. R., Boillos, M. G., Ramírez, P. A. P., Rojas‐Marcos, P. M., Guayerbas, L. C., Cano, A. M. G., Ruiz-Sánchez, J. G., Vicente, A., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02563-y · Cited by 1 · see citing works
Parksook, W. W., Heydarpour, M., Brown, J. M., Turchin, A., Mannstadt, M., & Vaidya, A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14840 · Cited by 1 · see citing works
Castro, M. A., Corrales, E. P., Fernández-Argüeso, M., BENGOA-ROJANO, N., Cano, A. M. G., Mendiguchía, L. J., & Cuesta, M. (2023) · Minerva Endocrinology · doi:10.23736/s2724-6507.23.03866-6 · Cited by 1 · see citing works
Magnesium and Its Interdependency with Other Cations in Acute and Chronic Stressor States
Komolafe, B. O., Khan, M. U., Khouzam, R. N., Dishmon, D. A., Newman, K. P., McGee, J. E., Bhattacharya, S. K., & Weber, K. T. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-044-1_17
Die Rolle von Aldosteron im Knochenstoffwechsel
Tomaschitz, A., Kienreich, K., Fahrleitner‐Pammer, A., & Pilz, S. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Les effets délétères de la parathormone sur le coeur
Ritz, D., & Nourrit-Poirette, F. (2011) · Néphrologie & Thérapeutique · doi:10.1016/s1769-7255(11)70006-2
Renal excretion function in primary hyperparathyroidism: cardio-renal syndrome
Mirnaya, S. S., Сергеевна, М. И., Dobreva, E. A., & Mokrysheva, N. G. (2021) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2021-25-1-59-69
Castro, M. A., Corrales, E. P., Fernández-Argüeso, M., Rojano, N. B., Cano, A. M. G., Mendiguchía, L. J., & Cuesta, M. (2021) · Research Square · doi:10.21203/rs.3.rs-1003319/v1
Yanevskaya, L. G., Pogosian, K., Semenova, A. N., Chernikov, R. A., Buzanakov, D. M., Belyaeva, О. D., Grineva, E. N., & Каронова, Т. Л. (2021) · Consilium Medicum · doi:10.26442/20751753.2021.12.201235
(2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328341311d
(2009) · Surgery · doi:10.1016/s0039-6060(09)00708-9
Güneş, E., & Güneş, M. (2023) · DergiPark (Istanbul University) · doi:10.47582/jompac.1324604
Hiperaldosteronismo e hiperparatiroidismo. Una amistad inquietante
Navarro, J. A. M., Zahonero, L. M., Procaccini, F., Teba, R. B., Menéndez, V. R., Álvarez, E. V., Cánovas, M. E. P., Ortega-Díaz, M., Carretero, M. P., Valverde, R. L., et al. (2024) · Nefrología · doi:10.1016/j.nefro.2023.12.005
Hyperaldosteronism and hyperparathyroidism. A disturbing friendship
Navarro, J. A. M., Zahonero, L. M., Procaccini, F., Teba, R. B., Menéndez, V. R., Álvarez, E. V., Cánovas, M. E. P., Ortega-Díaz, M., Carretero, M. P., Valverde, R. L., et al. (2024) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2024.07.007
Sun, Z., & Liu, W. (2025) · SAGE Open Medicine · doi:10.1177/20503121251324797
Jones, A., Tan, J., Dao, T., Tan, J., Wong, P., Sztal‐Mazer, S., Milat, F., Yang, J., & Gilfillan, C. P. (2025) · Endocrine · doi:10.1007/s12020-025-04323-7
Cuny, T., Sahakian, N., Albarel, F., Vermalle, M., Morange, I., Brue, T. C., & Castinetti, F. (2025) · Annales d Endocrinologie · doi:10.1016/j.ando.2025.102189
Михайловна, Ч. Н., Blinova, N. V., Trushina, O. I., Podzolkov, V. I., Bragina, A. E., & Chazova, I. E. (2026) · Terapevticheskii arkhiv · doi:10.26442/00403660.2026.07.203747 · Cited by 1 · see citing works
Gheorghe-Milea, A., & Georgescu, C. E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1896180
- Authors
- Brunaud, L., Germain, A., Zarnegar, R., Rancier, M., Alrasheedi, S., Caillard, C., Ayav, A., Weryha, G., Mirallie, E., & Bresler, L.
- ORCID
- Venue
- Surgery
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 146
- Issue
- 6
- Pages
- 1035-1041
- ISSN
- 0039-6060 (ISSN-L)
- OpenAlex
- W2169367554
- Cited by
- 83
- References
- 25
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 11
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- primary hyperparathyroidism, serum aldosterone, parathyroid hormone, parathyroidectomy, cardiovascular morbidity, antihypertensive drugs
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aldosterone, Antihypertensive Agents, Calcium, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Parathyroid Hormone, Prospective Studies, Risk Factors, Time Factors, Parathyroidectomy, Hyperparathyroidism, Primary, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
